Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) Debt Ratio (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Debt Ratio for 4 consecutive years, with 0.04 as the latest value for Q3 2025.

  • On a quarterly basis, Debt Ratio rose 6.78% to 0.04 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.04, a 6.78% increase, with the full-year FY2024 number at 0.04, up 20.23% from a year prior.
  • Debt Ratio was 0.04 for Q3 2025 at Spruce Biosciences, down from 0.04 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.06 in Q4 2022 to a low of 0.03 in Q4 2023.
  • A 4-year average of 0.04 and a median of 0.04 in 2025 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: plummeted 44.02% in 2023, then increased 28.24% in 2025.
  • Spruce Biosciences' Debt Ratio stood at 0.06 in 2022, then tumbled by 44.02% to 0.03 in 2023, then increased by 20.23% to 0.04 in 2024, then decreased by 8.86% to 0.04 in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Debt Ratio are 0.04 (Q3 2025), 0.04 (Q2 2025), and 0.04 (Q1 2025).